Kent W. Christopherson

3.6k total citations · 1 hit paper
46 papers, 2.9k citations indexed

About

Kent W. Christopherson is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Kent W. Christopherson has authored 46 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 15 papers in Molecular Biology and 15 papers in Hematology. Recurrent topics in Kent W. Christopherson's work include Chemokine receptors and signaling (20 papers), Glycosylation and Glycoproteins Research (10 papers) and Peptidase Inhibition and Analysis (9 papers). Kent W. Christopherson is often cited by papers focused on Chemokine receptors and signaling (20 papers), Glycosylation and Glycoproteins Research (10 papers) and Peptidase Inhibition and Analysis (9 papers). Kent W. Christopherson collaborates with scholars based in United States, France and South Korea. Kent W. Christopherson's co-authors include Hal E. Broxmeyer, Giao Hangoc, Robert Hromas, Charlie Mantel, Harikrishna Nakshatri, Scott Cooper, Poornima Bhat‐Nakshatri, Kathy D. Miller, Hiromitsu Kishimoto and Suresh Kumar and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kent W. Christopherson

44 papers receiving 2.8k citations

Hit Papers

NF-κ B Promotes Breast Cancer Cell Migration and Metastas... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
    2003 530 citations Kent W. Christopherson, Poornima Bhat‐Nakshatri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kent W. Christopherson United States 22 1.4k 1.0k 1.0k 622 354 46 2.9k
Charlie Mantel United States 34 1.5k 1.1× 1.2k 1.2× 1.9k 1.9× 1.2k 1.9× 511 1.4× 79 4.1k
Kevin Barton United States 21 722 0.5× 1.0k 1.0× 1.8k 1.8× 521 0.8× 261 0.7× 50 3.2k
Carlijn Voermans Netherlands 32 566 0.4× 845 0.8× 985 1.0× 780 1.3× 585 1.7× 73 2.7k
Héctor L. Aguila United States 33 995 0.7× 1.7k 1.7× 1.7k 1.7× 822 1.3× 579 1.6× 56 4.2k
H. Scott Boswell United States 29 594 0.4× 1.2k 1.2× 1.6k 1.6× 1.1k 1.7× 540 1.5× 63 3.6k
Lorraine Robb Australia 37 1.3k 0.9× 1.8k 1.8× 2.3k 2.2× 900 1.4× 329 0.9× 73 4.9k
Noriyoshi Kurihara United States 37 2.2k 1.6× 449 0.4× 2.4k 2.4× 553 0.9× 142 0.4× 106 4.3k
R E Gay Switzerland 29 650 0.5× 737 0.7× 1.2k 1.1× 331 0.5× 136 0.4× 64 3.2k
Tetsuo Sudo Japan 23 2.1k 1.5× 1.6k 1.6× 2.8k 2.8× 311 0.5× 190 0.5× 51 4.8k
Hideyo Hirai Japan 33 792 0.6× 1.4k 1.3× 1.4k 1.4× 794 1.3× 402 1.1× 105 3.4k

Countries citing papers authored by Kent W. Christopherson

Since Specialization
Citations

This map shows the geographic impact of Kent W. Christopherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent W. Christopherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent W. Christopherson more than expected).

Fields of papers citing papers by Kent W. Christopherson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent W. Christopherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent W. Christopherson. The network helps show where Kent W. Christopherson may publish in the future.

Co-authorship network of co-authors of Kent W. Christopherson

This figure shows the co-authorship network connecting the top 25 collaborators of Kent W. Christopherson. A scholar is included among the top collaborators of Kent W. Christopherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent W. Christopherson. Kent W. Christopherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karmali, Reem, Melissa L. Larson, Jamile M. Shammo, et al.. (2015). Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia. Leukemia & lymphoma. 56(11). 3135–3142. 8 indexed citations
2.
Usha, Lydia, Geetha Rao, Kent W. Christopherson, & Xiulong Xu. (2013). Mesenchymal Stem Cells Develop Tumor Tropism but Do Not Accelerate Breast Cancer Tumorigenesis in a Somatic Mouse Breast Cancer Model. PLoS ONE. 8(9). e67895–e67895. 13 indexed citations
3.
McNulty, Margaret A., et al.. (2012). Adult Stem Cell Mobilization Enhances Intramembranous Bone Regeneration: A Pilot Study. Clinical Orthopaedics and Related Research. 470(9). 2503–2512. 12 indexed citations
4.
Christopherson, Kent W., et al.. (2012). CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1. Experimental Hematology. 40(11). 945–952. 10 indexed citations
5.
Kidd, Shannon, Carlos E. Bueso‐Ramos, Laura A. Paganessi, et al.. (2011). In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice. Experimental Hematology. 39(5). 580–590.e1. 5 indexed citations
6.
Christopherson, Kent W., et al.. (2008). Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. The Journal of Immunology. 180(5). 3612–3612. 4 indexed citations
7.
8.
9.
Li, Yu, Pradip De, Hua-Chen Chang, et al.. (2007). Rap1a Null Mice Have Altered Myeloid Cell Functions Suggesting Distinct Roles for the Closely Related Rap1a and 1b Proteins. The Journal of Immunology. 179(12). 8322–8331. 92 indexed citations
10.
11.
Starnes, Trevor, Kanwaldeep Kaur Rasila, Michael J. Robertson, et al.. (2006). The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: Implications for the downregulation of CXCL14 in malignancy. Experimental Hematology. 34(8). 1101–1105. 112 indexed citations
12.
Christopherson, Kent W., Poornima Bhat‐Nakshatri, Robert J. Goulet, et al.. (2006). Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene. 26(23). 3329–3337. 91 indexed citations
13.
Christopherson, Kent W., et al.. (2006). G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38− human cord blood hematopoietic cells. Experimental Hematology. 34(8). 1060–1068. 43 indexed citations
14.
Christopherson, Kent W. & Robert Hromas. (2004). Endothelial Chemokines in Autoimmune Disease. Current Pharmaceutical Design. 10(2). 145–154. 12 indexed citations
15.
Ramsey, H. E., Kent W. Christopherson, & Robert Hromas. (2004). Forced expression of AML1–AMP19, a fusion transcript generated from a radiation-associated t(19;21) leukemia, blocks myeloid differentiation. Leukemia Research. 28(8). 863–868. 4 indexed citations
16.
Christopherson, Kent W., James J. Campbell, Jeffrey B. Travers, & Robert Hromas. (2002). Low-Molecular-Weight Heparins Inhibit CCL21-Induced T Cell Adhesion and Migration. Journal of Pharmacology and Experimental Therapeutics. 302(1). 290–295. 42 indexed citations
17.
Hromas, Robert, Hal E. Broxmeyer, Chang H. Kim, et al.. (1999). Cloning of BRAK, a Novel Divergent CXC Chemokine Preferentially Expressed in Normal versus Malignant Cells. Biochemical and Biophysical Research Communications. 255(3). 703–706. 167 indexed citations
18.
Hromas, Robert, et al.. (1999). Isolation of ALP, a Novel Divergent Murine CC Chemokine with a Unique Carboxy Terminal Extension. Biochemical and Biophysical Research Communications. 258(3). 737–740. 22 indexed citations
19.
Bedford, Fiona K., Kent W. Christopherson, Mark W. Nachtigal, et al.. (1996). Molecular Biology of Pituitary Development and Disease. Hormone Research. 45(1). 19–21. 3 indexed citations
20.
Wakefield, Lalage M., et al.. (1990). Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.. Journal of Clinical Investigation. 86(6). 1976–1984. 262 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlie Mantel Breakdown of academic impact, for papers by Kevin Barton Breakdown of academic impact, for papers by Carlijn Voermans Breakdown of academic impact, for papers by Héctor L. Aguila Breakdown of academic impact, for papers by H. Scott Boswell Breakdown of academic impact, for papers by Lorraine Robb Breakdown of academic impact, for papers by Noriyoshi Kurihara Breakdown of academic impact, for papers by R E Gay Breakdown of academic impact, for papers by Tetsuo Sudo Breakdown of academic impact, for papers by Hideyo Hirai
Rankless by CCL
2026